Abstract
Mammalian acetylcholinesterase (AChE) is well-studied, being important in both cholinergic brain synapses and the peripheral nervous systems and also a key drug target for many diseases. In contrast, little is known about the structures and molecular mechanism of prokaryotic acetylcholinesterases. We report here the structural and biochemical characterization of ChoE, a putative bacterial acetylcholinesterase from Pseudomonas aeruginosa. Analysis of WT and mutant strains indicated that ChoE is indispensable for P. aeruginosa growth with acetylcholine as the sole carbon and nitrogen source. The crystal structure of ChoE at 1.35 Å resolution revealed that this enzyme adopts a typical fold of the SGNH hydrolase family. Although ChoE and eukaryotic AChEs catalyze the same reaction, their overall structures bear no similarities constituting an interesting example of convergent evolution. Among Ser-38, Asp-285, and His-288 of the catalytic triad residues, only Asp-285 was not essential for ChoE activity. Combined with kinetic analyses of WT and mutant proteins, multiple crystal structures of ChoE complexed with substrates, products, or reaction intermediate revealed the structural determinants for substrate recognition, snapshots of the various catalytic steps, and the molecular basis of substrate inhibition at high substrate concentrations. Our results indicate that substrate inhibition in ChoE is due to acetate release being blocked by the binding of a substrate molecule in a nonproductive mode. Because of the distinct overall folds and significant differences of the active site between ChoE and eukaryotic AChEs, these structures will serve as a prototype for other prokaryotic acetylcholinesterases.
Keywords: acetylcholinesterase, crystal structure, enzyme catalysis, catalytic triad, substrate inhibition, nonproductive binding, convergent evolution, acyl-enzyme, serine esterase, Pseudomonas aeruginosa, acetylcholinesterase (AChE)
In mammals, acetylcholinesterase (AChE) plays a pivotal role in cholinergic brain synapses and neuromuscular junctions through the termination of impulse transmission via rapid hydrolysis of acetylcholine (ACh), an important cationic neurotransmitter in the nervous system (1). The rapid hydrolysis of ACh into acetic acid and choline by AChE is achieved at a rate close to that of a diffusion-controlled reaction and, therefore, AChE is recognized as one of the most efficient enzymes in nature (2). Having a catalytic triad consisting of Ser, His, and Glu residues, AchE follows the classical esterase mechanism (3) and two half-reactions are required to complete the full catalytic cycle.
In recent decades, the structure and function study of the AChEs from metazoans has been particularly important in the context of the development of inhibitors to block the activity of AChE for various purposes, e.g. the treatment of Alzheimer's disease (4). The first crystal structure of an acetylcholinesterase from Torpedo californica (TcAChE) was published nearly 30 years ago (5). This was followed by the determination of ∼250 structures of AChEs of eukaryotic sources, many of which are in complex with various inhibitors (6). Despite the long history of research on structure and inhibition of eukaryotic AChEs (7, 8), novel insights have been gained into these pivotal enzymes in recent years, e.g. the dynamics of back door opening (9), the steric and dynamic parameters implicated in the reaction within the active-site gorge (10), and the possible repurposing of AChE inhibitors as anti-cancer agents (11).
ACh hydrolyzing activity has also been recognized in many prokaryotic species from various bacterial classes (12) although they lack a nervous system. This was especially the case for the bacteria from the Pseudomonas genus, which are able to inhabit a large range of environments with many species such as Pseudomonas aeruginosa being pathogens for many different hosts (13). Acetylcholinesterase activity has been observed in Pseudomonas fluorescens after growth with ACh as the sole source of carbon (14, 15). The putative acetylcholinesterase from P. aeruginosa strain PAO1, named ChoE, has also been characterized (12, 16). Despite its small size (287 residues) relative to that of eukaryotic AChEs (∼560 residues), ChoE is able to catalyze the hydrolysis of both acetylthiocholine (ATCh) and its analog propionylthiocholine (PTCh). The purified ChoE enzyme of P. aeruginosa is inhibited by substrate at high substrate concentrations, exhibiting enzymatic properties similar to eukaryotic AChEs (12). In view of the enzymatic activity of ChoE as well as the abundance of ACh present in the corneal epithelium (17), it was proposed that ChoE could be a virulence factor involved in corneal infection by P. aeruginosa (18). Production of choline by ChoE for subsequent catabolic processes by other metabolic pathways was also suggested to be linked to the pathogenicity of P. aeruginosa and its survival during murine lung infection (19, 20).
In contrast to the eukaryotic AChEs, little is known about the structure and molecular mechanism of prokaryotic acetylcholinesterases. Due to the low sequence identity (<26%) between ChoE and the proteins whose structures are available in the Protein Data Bank (PDB), it remains elusive how this enzyme works at the molecular level. In this study, we have performed structural and biochemical characterization of ChoE. Multiple structures were determined at a resolution of 1.35-1.85 Å in the presence of substrates, products, or reaction intermediate using both WT and the catalytic triad mutants. These results have uncovered the first atomic details of a putative bacterial acetylcholinesterase and provided insights into the mechanism of substrate inhibition.
Results
ChoE is required for P. aeruginosa to utilize ACh as the sole source of carbon and nitrogen
Choline can serve as the sole source of carbon and nitrogen to support P. aeruginosa growth and can be acquired through an acetylcholinesterase activity of ChoE, encoded by the choE (PA4921) gene (12). Growth of the WT PAO1 strain and the deletion mutant strain PAO1::ΔPA4921 (PW9287) was assessed in a microplate reader at 37 °C and both strains were unable to grow in salt solution containing 0.66% KH2PO4, 0.3% K2HPO4, and 0.3% MgSO4, unless choline was added as a source of carbon and nitrogen. The WT strain was able to use ACh as a substrate, but the mutant strain could not (Table 1). These results confirmed that ChoE is required for the bacteria to grow when ACh is the sole source of carbon and nitrogen.
Table 1.
P. aeruginosa growth in salt solution supplemented or not with choline or acetylcholine
| Salt solution | Salt solution with 20 mm choline | Salt solution with 20 mm acetylcholine | |
| WT strain (PAO1) | −a | ++ | + |
| Mutant strain (PAO1::ΔPA4921) | − | ++ | − |
aGrowth is shown by a plus (+) or a double plus (++), according to the extent of growth, and no growth by a minus (−). The results were obtained from two technical replicates of two biological replicates.
Characterization of WT and mutant ChoE
Using both ATCh and PTCh substrates, we studied the enzyme kinetics of WT ChoE and mutants of the catalytic triad and substrate-binding residues. Our results showed that WT ChoE has similar activity on ATCh and PTCh (Table 2 and Fig. 1A). Based on the apparent catalytic efficiency (kcat/Km), ChoE exhibits slightly higher specificity on PTCh, consistent with the previous report (12). Using an elevated concentration (30 nm) of ChoE, we also detected its activity toward butyrylthiocholine (BTCh) (Table 2 and Fig. 1A) in contrast to the previous report in which a lower concentration of enzyme was used (12). In our assays, substrate inhibition was observed at high concentrations of the substrate with a KSI(app) of 0.9 mm for ATCh. Substrate inhibition was modeled upon the mechanism first described by Krupka (21) that considered substrate inhibition of AChE as arising from trapping an EIS (acyl-enzyme intermediate substrate complex) at high substrate concentrations. Such EIS complex of ChoE would be kinetically undistinguishable from an EPS complex (enzyme product-substrate ternary complex) and is thus fully consistent with the EPS observed in the crystal structures of ChoE (see below). Although the kinetic data could be equally well fitted with a model describing inhibition as arising from the formation of an enzyme-substrate-substrate complex (ESS, Table 2), as assumed by Sánchez et al. (12), an ESS inhibitory complex of ChoE appears unlikely given the lack of evidence of a second substrate-binding site by crystallography.
Table 2.
Kinetic data of WT ChoE and mutants
| Enzyme | Substrate | kcat(app) | Km(app) | KSI(app) | kcat/Km |
|---|---|---|---|---|---|
| s−1 | mm | M−1 s−1 | |||
| WTa | ATCh | 200 ± 25 | 0.10 ± 0.02 | 0.9 ± 0.2 | 2.0 × 106 |
| S38A | ATCh | -b | - | - | - |
| H288N | ATCh | - | - | - | - |
| D285Nc | ATCh | 5.0 ± 0.3 | 1.6 ± 0.4 | - | 3.1 × 103 |
| Y106Ac | ATCh | 99 ± 4 | 2.15 ± 0.25 | - | 4.6 × 104 |
| W287Ac | ATCh | 214 ± 9 | 1.64 ± 0.18 | - | 1.3 × 105 |
| WTa | PTCh | 316 ± 43 | 0.07 ± 0.02 | 1.0 ± 0.3 | 4.5 × 106 |
| S38A | PTCh | - | - | - | - |
| H288N | PTCh | - | - | - | - |
| D285Nc | PTCh | 6.2 ± 0.2 | 0.28 ± 0.05 | - | 2.2 × 104 |
| Y106Ac | PTCh | 179 ± 5 | 1.37 ± 0.11 | - | 1.3 × 105 |
| W287Ac | PTCh | 190 ± 5 | 1.60 ± 0.13 | - | 1.2 × 105 |
| WTa | BTCh | 6.2 ± 0.2 | 0.024 ± 0.004 | 6.2 ± 0.9 | 2.6 × 105 |
| WTc | pNPA | 83 ± 13 | 0.8 ± 0.3 | - | 1.0 × 105 |
| WTc | pNPP | 439 ± 45 | 0.35 ± 0.10 | - | 1.2 × 106 |
| WTc | pNPB | 5.8 ± 0.3 | 0.12 ± 0.01 | - | 4.8 × 104 |
| WT | pNPO | - | - | - | - |
| WTa | ATCh + PI | 10.2 ± 0.7 | 0.1 ± 0.02 | 11.9 ± 4.3 | 1.0 × 105 |
| WTa | ATCh + TEAC | 57.6 ± 1.8 | 0.06 ± 0.01 | 175 ± 104 | 9.6 × 105 |
aFit to Equation 1 (Krupka) (21) and “Materials and methods.” Fit to Equation 2 gave identical values.
bUnmeasurable.
cFit to Michaelis-Menten equation (Equation 3).
Figure 1.
Equilibrium kinetic studies of WT ChoE and the D285N mutant. Saturation kinetic curves of WT ChoE displayed substrate inhibition behavior with ATCh, PTCh, and BTCh but not those of the D285N mutant. A, the initial rates of WT ChoE measured at different concentrations of ATCh, PTCh, or BTCh were fitted to Equation 1 to obtain the values of kcat(app), Km(app), and KSI(app). The R2 values were 0.96 (ATCh), 0.94 (PTCh), and 0.97 (BTCh). B, the initial rates of the D285N mutant measured at different concentrations of ATCh or PTCh were fitted to Equation 3 to obtain the kcat(app) and Km(app) values. The R2 values were 0.96 (ATCh) and 0.97 (PTCh). C, the initial rates of WT ChoE measured at different concentrations of pNPA, pNPP, or pNPB were fitted to Equation 3 to obtain the kcat(app) and Km(app) values. The R2 values were 0.93 (pNPA), 0.96 (pNPP), and 0.99 (pNPB). D, the initial rates of WT ChoE measured in the presence of varying concentrations of ATCh and a constant concentration (1 mm) of inhibitor (TEAC or PI) were fitted to Equation 1 to obtain the values of kcat(app), Km(app), and KSI(app). The R2 values were 0.97 (TEAC) and 0.98 (PI).
The enzymatic assays carried out with the catalytic triad mutants (S38A, D285N, and H288N) showed that the catalytic activity was abolished in both S38A and H288N mutants, whereas the D285N mutation diminished the enzymatic activity severely, indicating that both Ser-38 and His-288 are indispensable for ChoE to fulfill its hydrolase function (Table 2 and Fig. 1B). Notably, replacement of Asp-285 by an asparagine has led to a 40-fold reduction of kcat(app) together with an increase of Km(app) by 16-fold, reflecting a 640-fold drop of catalytic efficiency when ATCh is the substrate. The large impact on kcat(app) upon mutation indicates that Asp-285 is, albeit not essential, an important component of catalytic triad in ChoE. The kinetic analysis of the mutants of substrate-binding residues (Y106A and W287A) (Table 2 and Fig. S1) using ATCh and PTCh as substrates indicated that the Y106A mutation has led to less than ∼2-fold drop of kcat(app) but to a 14-20-fold increase of Km(app), whereas the W287A mutation has resulted in a small or no change of kcat(app) accompanied by a 16-fold increase of Km(app). Intriguingly, substrate inhibition is abolished for all three mutants D285N, Y106A, and W287A.
The kinetic analysis of ChoE with the substrates 4-nitrophenyl acetate (pNPA), 4-nitrophenyl propionate (pNPP), 4-nitrophenyl butyrate (pNPB), and 4-nitrophenyl octanoate (pNPO) demonstrated that ChoE exhibits a lower specificity on these p-nitrophenyl esters as compared with the ATCh and PTCh substrates (Table 2 and Fig. 1C). Importantly, the esters bearing extra C-C bonds beyond the propionyl group, such as pNPB and pNPO, are either not substrates or very poor substrates, consistent with our molecular docking in which the esters with a long tail could not be accommodated in the active site pocket with a proper geometry required for catalysis (Fig. S2). Taken together with the data on ATCh, PTCh, and BTCh, these results suggest that the substrates of ChoE with high specificity are limited to the esters having an acetyl or a propionyl group. Notably, no substrate inhibition was observed with two of the p-nitrophenyl esters (pNPA and pNPP). This may well be the case of the third substrate (pNPB) but because it was not soluble at more than 1 mm in our assay condition, the absence of substrate inhibition could not be verified with this substrate.
Prompted by the docking results (Fig. S2), we have also investigated the inhibitory effects of tetraethylammonium chloride (TEAC) and propidium iodide (PI), the latter of which is an inhibitor that can bind to either the peripheral anionic site (PAS) of mouse AChE (22) or the A-site of human butyrylcholinesterase (23). These two molecules contain a quaternary ammonium group, similar to ATCh and PTCh. Kinetic analysis has confirmed that the presence of either molecule at 1 mm could indeed inhibit the activity of ChoE leading to a 3.5-20-fold decrease of kcat(app) when ATCh was used as the substrate, whereas essentially not affecting Km(app). Interestingly, the KSI(app) values for substrate inhibition by ATCh were much higher (13-194–fold) in the presence of TEAC or PI (Table 2 and Fig. 1D).
ChoE adopts a typical fold of the SGNH hydrolase family
The DNA sequence encoding the signal peptide (residues 1-20) at the N-terminal was not included in our construct. All the residues (21-307) in the mature protein are built into the model because of the excellent quality of electron density maps. Having five β-strands with an order of β2-β1-β3-β4-β5 and 10 α-helices, ChoE has the characteristic α/β/α-globular fold of the SGNH hydrolase family (24, 25) (Fig. 2A). The most similar structures of ChoE, obtained through the DALI search (26), include the esterase EstJ15 (PDB 5XTU) (27), the phospholipase A2 VvPlpA (PDB 6JKZ) (28) (Fig. 2B), and the esterase EstA (29). However, these enzymes share a relatively low sequence identity of 23–26% with ChoE. Notably, EstJ15 has the same Ser-His-Asp catalytic triad as that in ChoE, whereas VvPlpA lacks the Asp residue in the catalytic triad of ChoE and EstJ15 and instead utilizes an unusual Ser-His-chloride catalytic triad to fulfill the catalysis (28). Similar to EstJ15 and VvPlpA, ChoE is monomeric based on size exclusion chromatography and the crystal structures. It is worth mentioning that, for the 10 most similar proteins retrieved from the DALI search, none contained a substrate or a product molecule in the active site. Quite remarkably, despite the same reaction being catalyzed by ChoE and eukaryotic AChEs, their overall structures bear no similarities.
Figure 2.
Overall structure of ChoE and comparison with its structural homologues. A, cartoon representation of ChoE. ChoE is painted in rainbow colors with the N-terminal in blue and the C-terminal in red. The catalytic triad residues Ser-38, Asp-285, and His-288 are shown in sphere representation. B, superposition of ChoE (colored in magenta), EstJ15 (27) (PDB 5XTU, colored in orange) and VvPlpA (28) (PDB 6JKZ, colored in cyan) via the Secondary Structure Matching (SSM) in Coot (71). The r.m.s.d. values for the aligned Cα atoms are 1.6 and 1.8 Å for EstJ15 (251 Cα atoms) and VvPlpA (231 Cα atoms), respectively. Both EstJ15 and VvPlpA have extra regions that are absent in ChoE, such as the long β-hairpin (residues 63-100, indicated by *) in EstJ15 or the N-terminal segment (residues 24-140, indicated by **) of VvPlpA.
The native ChoE structure
All the structures reported here were obtained from the crystallization conditions containing 100 mm MES buffer. The native ChoE structure determined at a resolution of 1.35 Å shows unambiguously the presence of a MES molecule in the substrate-binding pocket located at the center of ChoE (Fig. 3A). Calculation of electrostatic potential indicated that this pocket is negatively charged (Fig. 3B), a structural feature facilitating the entrapment of the positively charged quaternary ammonium moiety of the ACh substrate.
Figure 3.
Structure of ChoE with a MES molecule bound to its ligand-binding pocket. A, surface representation of ChoE. Both surface (colored in gray) and cartoon (colored in rainbow) representations are shown with the surface being transparent. The N- and C-terminal (denoted as N-ter and C-ter) are indicated. The MES molecule, shown in stick representation, is bound to the pocket at the center of protein. B, surface representation of ChoE, colored by electrostatic potential (ranging from −3 kBT/e (red) to 3 kBT/e (blue)) calculated via PyMol (Schrödinger), indicates that the ligand-binding pocket is largely negatively charged. ChoE in A and B adopt the same orientation. C, architecture of the ligand-binding pocket in ChoE. The MES molecule and the surrounding residues are shown in stick representation and water molecules are shown as red spheres. The residue Trp-73, located in front of both Ser-38 and His-288, is not shown to have a clear view of ligand-binding pocket. Hydrogen bonds are shown as dashed lines. The oxygen and nitrogen atoms are colored in red and blue, respectively. The Fourier difference map (Fo − Fc) with the MES molecule omitted from calculation is shown in green mesh and contoured at the 2σ level.
As shown in Fig. 3C, the MES molecule is bound to the substrate-binding pocket lined by the aromatic residues Trp-73, Tyr-106, Tyr-107, Phe-150, and Trp-287. At the bottom of the pocket are the catalytic residues Ser-38 and His-288 as well as the oxyanion hole composed of Gly-98 and Asn-147. Asp-285, the third residue forming the catalytic triad, is next to His-288, such that His-288 is within the hydrogen bonding distance (2.6-2.9 Å) of both Asp-285 and Ser-38, the pattern of which is similar to that of eukaryotic AChEs (5) and resembles that of serine proteases as well (30, 31). In this structure, the ethanesulfonic moiety of MES is exposed to the solvent and interacts with Tyr-107 and Asp-154 via water-mediated hydrogen bonds, whereas its morpholine ring is buried inside the pocket with its oxygen atom close to a well-defined water molecule (Wat-459) (3.2 Å) at the bottom of the pocket. Located at the center of the oxyanion hole, this water molecule is stabilized by the hydrogen bonds with the main chain amide groups of Ser-38 and Gly-98, the hydroxyl group of Ser-38 as well as the side chain amide group of Asn-147.
Both Asp-285 and His-288 are located at a U-turn loop where Asp-285 forms hydrogen bonds with the hydroxyl of Tyr-68 and the main chain amides of Glu-286, Trp-287, and His-288 at this loop. These interactions contribute significantly to the stabilization of the local structure as evidenced by the fact that the D285A mutant is insoluble, presumably due to the perturbation or disruption of the overall folding of the protein. Similarly, the imidazole ring of His-288 is sandwiched between Trp-73 and Trp-287 and also establishes van der Waals contacts with Tyr-39, suggesting a structural role of the His-288 side chain. To minimize the detrimental effects on the local structure and increase our chance to obtain structures of relevant protein-ligand complexes as exemplified in our previous work (32, 33), we mutated both Asp-285 and His-288 to an asparagine. Indeed, both D285N and H288N mutants showed similar behavior to the WT protein.
Structure of the ChoE H288N-ATCh complex
To obtain the ChoE complex bound with ATCh, we tried both co-crystallization and soaking methods using the crystals of WT enzyme and all three mutants, S38A, D285N, and H288N. Among these, soaking the H288N mutant crystals with 100 mm ATCh for 5 min gave the best result. In this H288N-ATCh complex, the ATCh substrate is clearly bound to the substrate-binding pocket (Fig. 4A). The overall structure is almost the same as the native one, with an r.m.s.d. value of 0.38 Å for all the Cα atoms. In the substrate-binding pocket, a few aromatic residues, such as Tyr-107 and Trp-287, undergo a minor shift or tilting in response to the substrate-binding event. Notably, contrary to the MES molecule captured in the native structure, the ATCh substrate molecule binds deeper and reaches the bottom of the pocket. As a result, the water molecule Wat-459 observed in the MES complex is expelled and, expectedly, this position is instead filled by the carbonyl oxygen of ATCh. The quaternary ammonium moiety of ATCh makes π-cation interactions with Tyr-106 and Trp-287, with the distances between the two closest carbon atoms being 3.5 and 3.9 Å, respectively. This part is further stabilized by van der Waals contacts with Tyr-107 and Phe-150. The carbonyl oxygen is anchored by multiple hydrogen bonds with Ser-38, Gly-98, and Asn-147, which form the oxyanion hole. The methyl group points to the acyl-binding pocket and establishes van der Waals contacts with Tyr-39, Ala-146, and Phe-150. The carbonyl carbon is only 2.4 Å away from the OG1 atom of Ser-38, which is consistent with the role of Ser-38 as a nucleophilic attacking group once it is deprotonated by His-288 of the catalytic triad. In this mutant structure, Asn-288 is still within the hydrogen bonding distance of both Asp-285 and Ser-38. Therefore, the ATCh binding mode in the WT protein is most likely very similar to the one described here for the H288N mutant.
Figure 4.
Binding of substrates, products, or reaction intermediate in the active site of ChoE. A, binding of ATCh in the active site pocket of the H288N mutant. Its carbonyl group is stabilized by hydrogen bonds with Ser-38, Gly-98, and Asn-147. B, binding of PTCh in the active site pocket of WT ChoE. Ser-38 adopts two conformations here. C, the acyl-enzyme structure of the D285N mutant. The propionyl group is covalently linked to Ser-38. The water molecule located above the reaction intermediate is shown as a red sphere. D, superposition of the PTCh-bound and acyl-enzyme structures. The carbon atoms of the covalently-linked propionyl group, the TCh molecule, and Ser-38 are shown in yellow, whereas those of PTCh are colored in green. E, binding of the acetate (ACT) and TCh product molecules in the active site of WT ChoE. F, binding of the ACT and TCh product molecules in the active site of the D285N mutant. In both E and F, the hydrolysis products are bound in the same fashion and Ser-38 adopts the alternate conformation being away from His-288. G, the nonproductive binding mode of the ATCh substrate in the S38A-ACT-ATCh complex. In this binding mode, the ATCh molecule effectively blocks the pocket and prevents the departure of ACT. H, a different view of nonproductive binding of ATCh upon ∼60° rotation from G. The Fourier difference maps (Fo − Fc) with ligands omitted from refinement are colored in green and contoured at 2σ level. The hydrogen bonds are shown as dash lines.
Structure of the ChoE-PTCh complex
After many trials, the ChoE-PTCh complex was obtained via a quick soaking (∼2 min) of the WT ChoE crystals with 50 mm PTCh. In the two ChoE molecules in the asymmetric unit, the PTCh substrate is found only in one molecule (Fig. 4B) as the other one likely contains products (propionate and thiocholine (TCh)), similar to acetate (ACT) and TCh described below. As expected, the overall structure is almost the same as that of the H288N-ATCh complex. Because of the presence of one additional C-C bond and the intact His-288 residue in the binding pocket, PTCh displays some differences in its configuration as compared with the ATCh molecule in the H288N-ATCh structure, whereas the quaternary nitrogen and carbonyl oxygen of both PTCh and ATCh are kept at almost identical positions to maintain the π-cation interactions and hydrogen bonds described above for ATCh. This observation emphasizes the critical importance of the choline head and carbonyl moiety in ChoE-substrate recognition. The additional C-C bond in PTCh relative to ATCh is surrounded by Tyr-39, Ala-146, Phe-150, and Trp-287 with a short distance of 3.4 Å from Phe-150. The potential steric hindrance imposed by this hydrophobic acyl-binding pocket rationalizes the poor activity of ChoE on BTCh (one more carbon than PTCh) (Table 2).
A remarkable feature of the ChoE-PTCh complex is that the side chain of Ser-38 adopts two conformations with one hydrogen bonding to His-288, whereas the other one rotates away from His-288 and points toward Gly-97. Given the spatial arrangement of both conformations, only the first one would be compatible with deprotonation by His-288 in preparation for catalysis.
Comparison of substrate recognition between ChoE and eukaryotic AChEs
With structures of both ATCh- and PTCh-bound ChoE available, we could better visualize the similarity and difference between ChoE and eukaryotic AChEs. Consistent with its small size of 287 residues, ChoE possesses a relatively shallow tunnel to anchor the ligands, e.g. the ethanesulfonic oxgen of the MES molecule located on the protein surface is ∼11 Å away from the OG atom of Ser-38, as compared with TcAChE (537 residues) whose active site is buried at the bottom of a narrow gorge of ∼20 Å deep. As a result, the substrate molecule maintains its direction upon entry into the tunnel/pocket until it reaches the catalytic site in ChoE (Fig. 5A). This is in sharp contrast to TcAChE in which the long axis of substrate at the catalytic anionic site (CAS) is perpendicular to the entry path (Fig. 5B). The functionally important peripheral anionic site (PAS) in eukaryotic AChEs (34, 35) is thus absent in ChoE as the quaternary ammonium group of both ATCh and PTCh molecules bound in the substrate-binding pocket of ChoE is not far from the protein surface (Fig. 5A).
Figure 5.
Comparison of ChoE and TcAChE. A, the relatively shallow pocket for substrate (PTCh) binding in ChoE, shown in a transparent surface. The catalytic triad residues Ser-38, Asp-285, and His-288 are shown in stick representation while the PTCh substrate is shown in sphere representation. B, the active site of TcAChE (PDB 2C5F) (34), the representative of eukaryotic AChEs, is located at the bottom of the gorge. The nonhydrolysable substrate analog OTMA (4-oxo-N,N,N-trimethylpentanaminium) molecules, shown in sphere mode, are bound at both the PAS and CAS with the one at the CAS site being almost perpendicular to the one at the PAS site. The catalytic triad residues Ser-200, Glu-327, and His-440 are at the CAS. C, the spatial arrangement of the catalytic triad (Ser-38, Asp-285, and His-288) and the two aromatic residues (Tyr-106 and Trp-287) important to anchor the quaternary ammonium moiety of substrate in ChoE. D, the architecture of the catalytic triad in TcAChE differs from that in ChoE, whereas the quaternary ammonium moiety of choline head is also stabilized by two aromatic residues Trp-84 and Phe-330.
Another drastic difference between ChoE and eukaryotic AChEs lies in the spatial arrangement of the catalytic triad residues. In ChoE, the side chains of Asp-285, His-288, and Ser-38 are almost linearly arranged, whereas those of Glu-327, His-440, and Ser-200 in TcAChE, albeit having a planar array, form a triangle (Fig. 5, C and D). This is due to the difference of overall folding and the distinct structural elements harboring the catalytic residues in these two enzymes. Importantly, Ser-200 in TcAChE is located at the sharp turn of a strand-turn-helix motif, the so-called nucleophile elbow, commonly seen in the α/β-hydrolase-fold enzymes (36, 37). In contrast, such structural feature is absent in ChoE and other members of the SGNH hydrolase family (25). Moreover, the residues forming the oxyanion hole also differ in these enzymes: TcAChE utilizes the backbone amide groups of three residues (Gly-118, Gly-119, and Ala-201), whereas the oxyanion hole of ChoE is formed by the backbone amides of both Gly-98 and the catalytic residue Ser-38 as well as the side chain amide of Asn-147 (Fig. 4, A and B).
Despite these differences, a striking resemblance between ChoE and eukaryotic AChEs was observed concerning the strategy employed by these enzymes to recognize the substrate: in both enzymes, the substrate-binding pocket is delineated by a series of aromatic residues, two of which (Tyr-106 and Trp-287 in ChoE or Trp-84 and Phe-330 in TcAChE) play a pivotal role in stabilizing the quaternary ammonium group of substrates, i.e. the choline head, via π-cation interactions (Fig. 5, C and D). The significant increase of Km(app) of both Y106A and W287A mutants (Table 2) have unequivocally confirmed the importance of both Tyr-106 and Trp-287 in anchoring the substrates. In addition to these two aromatic residues, the acyl-binding pocket of both enzymes is formed by several hydrophobic residues conferring substrate specificity.
Trapping of the reaction intermediate in the D285N mutant structure
Inspired by the kinetic results that the D285N mutant exhibits significantly lower activity, we crystallized the D285N mutant followed by soaking with either ATCh or PTCh molecule with the aim to capture a reaction intermediate. Indeed, a short soaking (2 min) of crystals in the presence of 50 mm PTCh has led to the visualization of an acyl-enzyme intermediate. In both ChoE molecules in the asymmetric unit, strong electron density continuously extends beyond the OG atom of Ser-38 and is best modeled as a covalently bound propionyl group at 100% occupancy (Fig. 4C). Comparison with the PTCh-bound ChoE structure indicated that the binding pocket does not have major changes except that the plane containing the propionyl moiety rotates ∼60° from its reactant position to bring the carbonyl carbon atom into covalent bonding distance of the OG atom of Ser-38 (Fig. 4D). This way, the carbonyl oxygen maintains all H-bonds with the residues forming the oxyanion hole. Although Asn-285 adopts a conformation similar to that of Asp-285, its H-bonding interactions with His-288 are now weaker, as evidenced by the change of distance from 2.9 to 3.2 Å (or 3.5 Å in molecule B) due to a slight shift of its side chain. Located above the reaction intermediate is a TCh molecule whose quaternary ammonium group is clearly visible but the thiol moiety is weaker in the electron density maps, probably due to the existence of two or more conformations and/or lack of stabilization interactions from the binding pocket (Fig. 4C). Nevertheless, its quaternary ammonium group occupies almost the same position as that of PTCh and is also stabilized by the π-cation interactions with Tyr-106 and Trp-287.
Notably, a round electron density is found above the covalently-linked intermediate and is best modelled as one water molecule, which is within the H-bonding distances of both His-288 (3.2 Å) and the carbonyl oxygen (3.0 Å) and is 3.2 Å away from the carbonyl carbon of reaction intermediate. Due to the replacement of Asp-285 by Asn, the pKa of His-288 is likely decreased and thus the deprotonation of this water by His-288 would be less efficient, retarding the deacylation step. Particularly in the current structure, and in contrast to the native enzyme, the NE2 atom of His-288 is presumably protonated given that it is merely 2.9 Å away from the OG atom of the acyl intermediate. This most likely scenario of His-288 being protonated would further impede the deacylation step leading to the entrapment of reaction intermediate in this mutant structure. In the second molecule of ChoE acyl-enzyme in the asymmetric unit, the corresponding water molecule has weaker electron density and is 3.4 Å away from His-288.
Product binding mode of ChoE
As mentioned above, product molecules, TCh and propionic acid, were observed in one of the two ChoE molecules in the asymmetric unit upon soaking WT crystals with 50 mm PTCh. Similarly, through soaking crystals with ATCh, we have also obtained the structures of WT (Fig. 4E) and D285N mutant (Fig. 4F) complexed with acetate and TCh, the products of ATCh hydrolysis. Comparison of the immediate environments of Asp-285 and Asn-285 revealed that the imidazole ring of His-288 slightly tilted upon the D285N mutation. In all these structures, the quaternary ammonium group of TCh is found to be placed at a position similar to the ones described above. In addition to the π-cation interactions with Tyr-106 and Trp-287, the positively charged moiety of TCh is further stabilized by the acetate molecule through electrostatic interactions with a distance of 3.8-4.1 Å between its quaternary nitrogen and the oxygen atom of the latter. This moiety could be easily identified due to its pyramid shape (Fig. 4F and Fig. S3) but the thiol moiety is more mobile possibly due to its exposure to the solvent (protein surface) and the lack of stabilizing interactions with nearby protein residues. Thus, the position of the thiol moiety of TCh modeled in these product complexes is less reliable. In contrast, the acetate molecule could be unambiguously located largely because of the stabilizing effects rendered by five hydrogen bonds with Ser-38 (both main chain amide and side chain), Gly-98, Asn-147, and His-288. A prominent feature of all these acetate-bound structures is that Ser-38 adopts the alternate conformation, i.e. the one rotating away (3.7 Å) from His-288. Most probably, this “resting” conformational state of Ser-38 is driven by its better geometry to form hydrogen bonding interactions with the acetate molecule trapped at the oxyanion hole.
Structure of the ChoE S38A-acetate-ATCh complex
Considering the fact that product molecules were routinely observed in the structure when WT proteins were used for co-crystallization or soaking experiments with the ATCh substrate, we resorted to the mutant proteins to gain insights into the structural basis of substrate inhibition. This approach has resulted in the structure of the S38A mutant bound with both acetate and ATCh when the mutant crystal was soaked 3 min with 100 mm ATCh. Both acetate and the substrate ATCh molecules were clearly visible in the electron density maps (Fig. 4, G and H). Because S38A has no detectable activity, the acetate molecule most likely came from the autohydrolysis of ATCh, in the stock solution before the soaking experiment or during the soaking step. No noticeable differences were observed in the immediate environment of Ala-38 when compared with the WT structures. Of note, despite the absence of hydroxyl group at Ala-38, the binding mode of acetate is almost identical to the one in the product complex of WT ChoE.
Because of the presence of an acetate molecule at the bottom of the pocket, the ATCh substrate binds differently from the one observed for the productive binding mode. This new nonproductive position of ATCh causes a slight shift or tilting of both Tyr-106 and Trp-287. As a result, the π-cation interactions between its quaternary ammonium moiety and these two aromatic residues are well maintained. This positively charged moiety also establishes the electrostatic interactions with the acetate buried beneath. Moreover, the parallel packing of the acetyl thiol moiety against the Trp-287 indole ring further stabilizes the ATCh molecule in this new binding mode. Additional van der Waals contacts come from Trp-73, Tyr-107 and Phe-150. This new positioning of ATCh exposes its sulfur and carbonyl carbon atoms to the solvent.
Discussion
We report here the structural and biochemical characterization of ChoE, a putative bacterial acetylcholinesterase from P. aeruginosa. Our enzyme kinetic analysis and structural data indicated that ChoE mainly catalyzes the hydrolysis of esters bearing an acetyl or a propionyl group. Although future investigation is required to unambiguously define the bona fide or physiological substrate of ChoE being acetylcholine, our results showed that ChoE is indispensable for P. aeruginosa to grow when acetylcholine is provided as the sole carbon and nitrogen source. On the other hand, we cannot exclude the possibility that other known bacterial esterase(s) may have the acetylcholinesterase activity. Nevertheless, to the best of our knowledge, the structural features governing the binding of choline head (quaternary ammonium group) have not been previously documented in the literature on bacterial esterases and therefore the structures presented here are the first of this kind. Using both WT and mutant proteins, we have successfully determined a comprehensive set of ChoE structures in complex with substrates, products, or reaction intermediate. In combination with the kinetic analysis of WT and mutant proteins, these results have provided molecular insights into the active site architecture, catalytic mechanism, and structural basis of substrate inhibition in bacterial acetylcholinesterases.
As described above, ChoE and eukaryotic AChEs differ in many aspects, including their overall structure, active site architecture, spatial arrangement of catalytic triad as well as the composition of oxyanion hole, the last two of which are largely because ChoE and eukaryotic AChEs do not bear any similarity in their overall structures. Our kinetic studies of ChoE indicated that the Km(app) value for the ATCh/ACh substrate is similar between ChoE (1 × 10−4 m) and the eukaryotic AChEs (5 × 10−5 m), whereas the kcat(app) (200 s−1) of ChoE is lower than that (104 s−1) of eukaryotic AChEs (38, 39). Overall, the apparent kcat/Km (2 × 106 versus 2 × 108 m−1 s−1) is about 2 orders of magnitude lower in ChoE, which may not be surprising as AChEs possess unique structural features and are highly efficient enzymes that approach the upper limit allowed by diffusion of the substrate (1, 2). It should be noted that a similar kinetic analysis of ChoE conducted previously at 37 °C revealed a higher kcat/Km value of ∼1 × 107 m−1 s−1 (12). The comparable Km(app) values between ChoE and AChEs may be explained by the fact that the structural determinants for substrate recognition in both ChoE and AChEs share significant similarity with the π-cation interactions being pivotal on anchoring the quaternary ammonium group of the substrate. This comes as no surprise from an evolutionary point of view. Search through the Protein Data Bank yielded a series of proteins that bind acetylcholine or choline, e.g. acetylcholine-binding protein AchBP (PDB 3WIP) (40), cell wall endolysin (PDB 1OBA) (41), and choline-binding protein OpuBC (PDB 3R6U) (42). Inspection of these structures revealed the widespread presence of π-cation interactions between the quaternary ammonium of choline head and its surrounding aromatic residues in these proteins despite their different foldings.
Different from human AChE (43) and some hydrolases of the SGNH family, such as AlgX (44) and AXE2 (45) in which mutation of any catalytic triad residues abolishes detectable activity, Asp-285 in the catalytic triad of ChoE is important but not essential for catalysis. Indeed, for some other enzymes in the same SGNH family, replacement of catalytic residues by alanine does not necessarily lead to inactive enzymes, as evidenced by the cases of EstD1 (46), AlgJ (47), and TAP (48). The similar arrangement of the catalytic triad in ChoE and other hydrolases in the SGNH family indicates the conserved role of these catalytic residues as illustrated in Fig. 6. Ser-38, once deprotonated by His-288, functions as a nucleophile to attack the carbonyl carbon of ACh. His-288 is critical for both acylation and deacylation steps as it deprotonates Ser-38 in the first half-reaction and one water molecule in the second half-reaction. The residues forming the oxyanion hole are critical to stabilize the negative charge built up on the tetrahedral intermediates. Asp-285 hydrogen bonds to the imidazole ring of His-288 and significantly increases the pKa of His-288 facilitating the role of the latter. A 40-fold kcat(app) reduction for the D285N mutant is consistent with its role in initiating the catalysis. We have also observed a 16-fold increase of Km(app) for this mutation with ATCh and to a lesser extent with PTCh. Although Asp-285 is not directly involved in substrate binding, the D285N mutation makes His-288 less electronegative and consequently favors the protonation state of Ser-38. A shift to the protonated Ser-38 will be less desirable to anchor the partially positively-charged carbonyl carbon thus decreasing the binding. Moreover, Ser-38 was observed to adopt two conformations: the “productive” conformation, positioned within the H-bonding distance of His-288, is prevalent when the substrate molecule is bound while the alternate “unproductive” conformer dominates in the presence of the acetate product as shown in the crystal structures of both WT and the D285N mutant. Therefore, the increase of Km(app) might also be due to the shift of the equilibrium of these two conformers of Ser-38 upon mutation of Asp-285 leading toward a preference for the alternate conformer and thus decreasing the binding affinity for substrate.
Figure 6.
Catalytic mechanism of ChoE. The spatial arrangement of catalytic triad (Asp-285–His-288–Ser-38) and the oxyanion hole, the latter of which is formed by two main chain amide groups (Ser-38 and Gly-98) and one side chain amide group (Asn-147), is shown in the free enzyme. The catalysis is initiated by the substrate binding event in the active site, i.e. formation of the enzyme-substrate complex. Upon the deprotonation by His-288, which functions as a base, Ser-38 attacks the carbonyl carbon of the substrate producing the tetrahedral intermediate I, which is followed by the release of choline and the formation of the acyl-enzyme intermediate. In this step, His-288 functions as an acid and returns the proton to form the leaving product (choline). Upon the recruitment of water to the acyl-enzyme intermediate, His-288 works as a base to deprotonate this water, which subsequently attacks the carbonyl carbon of the acyl-enzyme leading to the formation of the tetrahedral intermediate II. Finally, the second product acetic acid is released upon the reformation of the carbon–oxygen double bond. In this step, His-288 returns the proton to Ser-38 thus restoring the free enzyme ready for the next cycle of reaction. The residues forming the oxyanion hole are crucial in this mechanism in that they stabilize the negative charges built up in the tetrahedral intermediates.
Concerning the distinct rotamers adopted by Ser-38, it is worth mentioning that the alternate conformations of the serine residue in the catalytic triad are not rare, as evidenced by several other esterases or lipases including the acetylxylan esterase (49), the Bacillus subtilis lipase (50), the acetyl esterase HerE (51), and the feruloyl esterase (52). Such conformational flexibility of serine in the esterases may be more common than observed and could play an important role in fine-tuning the spatial reorganization of the catalytic triad in concert with the various steps of catalysis.
It is important to stress that the catalytic mechanism and the role of each catalytic triad residue in ChoE resemble those of eukaryotic AChEs (43, 53). In this regard, structurally distinct ChoE and AChEs constitute an intriguing example of convergent evolution by which these two enzymes have evolved to catalyze the same hydrolysis of acetylcholine. Indeed, previous systematic investigation has identified many such nonhomologous isofunctional enzymes, exemplified by the well-studied superoxide dismutases and glycosyl hydrolases (54–56). In particular, for the glycosyl hydrolases, enzymatic hydrolysis of the glycosidic bond is governed by the general acid catalysis and requires an Asp-Glu dyad of the same geometric arrangement although these enzymes have numerous different folds (56). The current study adds one more case to the growing list of hydrolases, which were more frequently present among nonhomologous isofunctional enzymes likely because one of their substrates is the ubiquitous water molecule and the catalysis typically requires no coenzyme (54).
An interesting observation in our study is that we have captured the acyl-enzyme intermediate of the D285N mutant at nearly neutral pH (pH 6.5) when PTCh was used in crystal soaking. Although this mutant is still active, its much lower efficiency provided us the time window to visualize this snapshot of catalysis. As previously pointed out, either the formation of acyl-enzyme or the deacylation step could be rate-limiting for canonical esterases (3). Trapping of acyl-enzyme in the D285N mutant indicates that deacylation is more likely the rate-limiting step in ChoE. The concurrent presence of the TCh in the pocket may prevent the water molecule (Fig. 4C) from being placed at the optimal trajectory to be deprotonated by His-288 and to attack the carbonyl carbon of the reaction intermediate.
Also importantly, the structure of the S38A-acetate-ATCh ternary complex provides a rationale for substrate inhibition in ChoE. Although crystals of the S38A mutant enzyme were used to trap this ternary complex, the binding mode of acetate is identical to that observed in the WT crystal, indicating that the hydroxyl group of Ser-38 does not significantly contribute to acetate binding. Therefore, we could extrapolate that the binding modes of both acetate and ATCh (or ACh) in this mutant structure would be maintained in the WT crystal. Based on this, at high concentrations of substrate, a substrate molecule could enter the pocket before the acetate product leaves the active site. In this case, the incoming substrate could not adopt the productive binding mode due to the presence of acetate in the oxyanion hole. Consequently, its acetyl moiety would be forced to turn away with its quaternary ammonium group still anchored by Trp-287 and Tyr-106, resulting in the new binding mode observed in the S38A-acetate-ATCh ternary complex. In this regard, the loss of substrate inhibition in both Y106A and W287A mutants (Table 2 and Fig. S1) has confirmed the importance of such binding mode in substrate inhibition. This nonproductive binding mode of substrate is reinforced by the electrostatic interactions between its quaternary nitrogen and the negatively charged acetate. This way, the substrate molecule effectively blocks the pocket prior to the departure of acetate leading to substrate inhibition. Notably, the KSI(app) value for ATCh has been very significantly elevated in the presence of tetraethylammonium or propidium, suggesting that these two molecules could compete efficiently with the event leading to substrate inhibition. This implies the potential involvement of these compounds in the formation of a “dead-end complex” before the departure of acetate from the active site pocket. Most likely, the presence of acetate would strengthen the binding of these molecules (positively charged at the quaternary nitrogen), leading to a decrease of the nonproductive binding of ATCh.
Further support for the mechanism proposed above is lent by the fact that substrate inhibition is also abolished in the D285N mutant. We should bear in mind that the bona fide leaving group after deacylation is acetic acid (CH3COOH), not acetate (CH3COO−) (Fig. 6). In the WT enzyme, this hydrolysis product could be easily deprotonated upon release in its immediate environment by His-288 as the pKa of the latter is increased in the presence of Asp-285. Notably, before the arrival of a new substrate, Ser-38 may adopt the unproductive alternate conformation as was observed, i.e. its hydroxyl being distant from His-288. During this short-time window, His-288 would be fully engaged for the deprotonation of acetic acid. Both events would strengthen the affinity for acetate in the oxyanion hole, thus slowing down its clearance/departure, and also promote the binding of the positively charged substrate in the nonproductive binding mode. With this reasoning, the D285N mutation is simply detrimental to this process, thus leading to the abolition of substrate inhibition. Of note, this substrate inhibition mechanism is partially analogous to that of eukaryotic AChEs. Indeed, a high concentration of substrate in AChEs results in the binding of two nonproductive substrates, one at CAS and the other at PAS, thus preventing the departure of acetate from the active site (34, 35). Also similarly, a negatively charged and conserved glutamate residue in AChEs plays an important role in anchoring one nonproductive substrate in the CAS pocket. Replacement of this glutamate by a smaller aspartate residue in both TcAChE and human AChE abolishs substrate inhibition (57–59), possibly because aspartate could somehow reposition the substrate molecule in the pocket thus allowing both deacylation and clearance of acetate to proceed (34).
Substrate inhibition is commonly observed in enzymes. Far from being an experimental oddity, it was shown to be physiologically important for some enzymes (60). Notably in eukaryotic AChEs, substrate inhibition is important for effective transmission of the neural signal (60). Considering that ChoE is likely involved in function(s) unrelated to neural signal transmission, it seems rather surprising that it is subjected to substrate inhibition with an apparent inhibition constant similar to that of eukaryotic AchE (∼1 mm). It is possible that substrate inhibition is a natural consequence for this type of enzyme due to the properties of the catalytic triad and the oxyanion hole that stabilize the acetate product. Otherwise, it is possible that the physiological context, in which P. aeruginosa benefits from substrate inhibition of ChoE, remains to be uncovered. Nonetheless, these results have established an interesting case of apparent convergent evolution whereby a similar catalytic mechanism and regulation by substrate inhibition are achieved through unrelated protein folds.
Collectively, our current study of ChoE has brought novel insights into the structure and function of prokaryotic acetylcholinesterases. Through extensive efforts of soaking experiments, we have captured the snapshots of different catalytic steps in ChoE, providing mechanistic insights into this enzyme. These first structures of a putative bacterial acetylcholinesterase will serve as a prototype for other cholinesterases of prokaryotic sources and will illuminate future studies on this family of enzymes. Last, the strategy we employed here, particularly the quick (2-5 min) soaking of crystals of WT and mutant enzymes with different substrates, may also be applied to the investigation of other hydrolases/esterases.
Materials and methods
Bacterial growth of WT and mutant P. aeruginosa in the presence of choline or acetylcholine
Bacterial strains used in this study are listed in Table S1. Bacteria from a pre-culture on tryptic soy agar were suspended to obtain an optical density at 595 nm (A595) of 0.1 in a salt solution (0.66% KH2PO4, 0.3% K2HPO4, and 0.3% MgSO4) supplemented or not with 20 mm choline chloride (Fisher Scientificm USA) or acetylcholine iodide (Sigma-Aldrich, USA). The incubation was performed in a flat-bottomed polystyrene 24-well–plate (Costar, USA) (600 μl of bacterial culture per well) in a microplate reader (Infinite 200 PRO NanoQuant TECAN) at 37 °C with an agitation at 200 rpm. Growth (A595) was assessed at the end of the incubation period (48 h).
Cloning, protein expression, and purification
The choE (PA4921, NP_253608.1) gene was amplified from chromosomal DNA of PAO1 by PCR without the first 60 nucleotides coding for a signal peptide. The forward primer PA4921_F (5′-GGTTAACGGATCCCACACATCCCCGCTGCTCGC-3′) and the reverse primer PA4921_R (5′-GGTTAACGAATTCTCAGCGCGCGTAGCGTGCCG-3′) were designed to introduce sites for digestion by the restriction enzymes BamHI and EcoRI, respectively. The PCR products were digested with BamHI and EcoRI and ligated into the pET28a (Novagen) vector encoding an N-terminal His tag. The constructed plasmid pET28a-choE was transformed into E. coli DH5α cells (Promega Biosciences). The sequence of the recombinant gene was confirmed by full-length Sanger DNA sequencing. The verified plasmid was transformed into E. coli BL21(DE3) cells (Novagen) for target gene overexpression. The protein expression was induced by 0.4 mm isopropyl β-d-1-thiogalactopyranoside followed by an overnight culture at 18 °C in Terrific Broth medium. After cell lysis and centrifugation, the protein was purified from supernatant by affinity chromatography using nickel-nitrilotriacetic acid beads (GE Healthcare, USA). The purity was further polished by a Hiload Superdex 200 column (GE Healthcare, USA) using protein buffer containing 20 mm Tris-HCl (pH 7.5), 150 mm NaCl, 2% glycerol, and 5 mm DTT.
Construction of ChoE mutants
PCR with the primers listed in Table S1 was performed on the genomic DNA of PAO1 and generated mutant choE fragments of 0.86 kb. Ser-38, Tyr-106, Asp-285, Trp-287, and His-288 were mutated to Ala-38, Ala-106, Ala-285 or Asn-285, Ala-287, and Asn-288, respectively. The Y106A, D285A, and D285N mutations were carried out by overlap-extension PCR, which consisted of two stages (48). First, two fragments with overlapping sequences were amplified by PCR, then a standard program of 15 cycles was employed after mixing these fragments and the WT choE gene as a template at the ratio of 1:1:1 without adding primers. Second, two primers, PA4921_F and PA4921_R, were added to amplify the full-length mutant sequence of choE. As Ser-38, Trp-287, and His-288 are close to the N and C terminus of ChoE, the forward S38A_F1 (for S38A mutation), reverse W287A_R1 (for W287A mutation), and H288N_R1 (for H288N mutation) long primers were designed for amplification to allow subcloning. The mutant genes were then subcloned and sequenced in the same manner as the aforementioned WT gene. The presence of the desired nucleotide substitutions was confirmed by DNA sequencing. The mutant proteins were expressed and purified following the same protocol for the WT protein.
Enzyme kinetic analysis of WT ChoE and mutants
A standard protocol was followed to measure the activity of ChoE using ATCh, PTCh, or BTCh as substrates (12, 61, 62) with minor modifications. Assays were conducted at 22 °C in 100 mm sodium phosphate buffer (pH 7.0), 0.33 mm 5,5-dithio-bis-(2-nitrobenzoic acid) for 3 min. Final ChoE concentrations in the reaction mixture were varied to optimize rates: 0.6 nm WT ChoE for the substrates ATCh and PTCh or 30 nm WT ChoE for the substrate BTCh was used. For the mutants, 30 nm enzyme was used for all the assays. Activities were measured using various concentrations of substrates in the range of 0.01-10 mm. The released thiocholine was monitored using a Cary spectrophotometer at 412 nm. The experiments were performed in triplicates from which the reported values of the kinetic parameters were obtained by fitting the WT data to Equation 1, originally obtained to describe inhibition studies of eukaryotic AChE in the context of substrate inhibition caused by the formation of an EIS complex (21). As explained by Krupka (21), Equation 1 was obtained by simply setting the exogenous inhibitor concentration to zero. Equation 1 would explain substrate inhibition equally well as being caused by the formation of an EIS complex or an EPS complex where the acyl bond would have been hydrolyzed within the active site. This equation is similar to Equation 2 that is frequently used to model substrate inhibition caused by binding of a second substrate molecule to the ES complex thus forming an ESS complex (60). Equations 1 and 2 differ only in that apparent constants are obtained by fitting data to Equation 1. Thus despite reflecting different mechanisms for substrate inhibition, the values of the kinetic parameters obtained with Equations 1 and 2 were identical (Table 2). When there was no substrate inhibition, the enzymatic kinetic data were analyzed with Equation 3 (Michaelis-Menten equation) as indicated in Table 2. Nonlinear least-squares regression analyses were performed using Kaleidagraph (Synergy Software).
| (Eq. 1) |
| (Eq. 2) |
| (Eq. 3) |
To measure the activity of ChoE on p-nitrophenyl esters, pNPA, pNPP, pNPB, and pNPO were all dissolved in DMSO. Following the protocol described previously (12), the assays were conducted at 22 °C in 100 mm sodium phosphate buffer (pH 7.0) for 3 min with a final volume of 1 ml of reaction mixture. The concentrations of ChoE were varied to optimize rates: 0.6 nm ChoE was used for the substrate pNPP, and 30 nm ChoE was used for the other substrates pNPA, pNPB, and pNPO. The released p-nitrophenol was monitored using a Cary spectrophotometer at 410 nm.
The inhibitory effects of TEAC and PI on the activity of ChoE were also studied. The concentration of each inhibitor was set at 1 mm. The assays were then conducted in the same manner as that described above for substrate ATCh.
Protein crystallization, data collection, structure determination and refinement, and structure comparison
For crystallization, ChoE was concentrated to 12 mg/ml. Crystals were grown at 4 °C using the microbatch-under-oil method by mixing 0.7 μl of 12 mg/ml of protein and 0.7 μl of reservoir solutions containing either a high concentration of salt (3 m NaCl, 100 mm HEPES, pH 7.5) or PEG molecules (15% (w/v) PEG 20000, 100 mm MES, pH 6.5; or 25% (w/v) PEG 8000, 100 mm MES, pH 6.5), the latter of which was obtained after optimization at the latter stage of this work. Typically, crystals appeared within 4 weeks in the condition containing 3 m NaCl, and 1 week in the condition containing PEG 8000 or PEG 20000. Upon the data collection for the first crystal form (from 3 m NaCl) in early 2018, we tried to determine the structure of ChoE by molecular replacement without success. For phasing purpose, crystals from 3 m NaCl were soaked in the reservoir solution supplemented with 400 mm I3C (5-amino-2,4,6-triiodoisophthalic acid) followed by the single-wavelength anomalous dispersion (SAD) data collection at the wavelength of 1.7712 Å at the 08ID-1 beamline, Canadian Light Source. To collect data for the other structures, crystals from the PEG conditions were soaked 2-5 min with 50-100 mm ATCh chloride or PTCh iodide and then cryoprotected using the reservoir solution supplemented with 12–16% ethylene glycol or 20% glycerol before flash freezing. The data were collected at the wavelength of 0.97931 Å at the LRL-CAT beamline at the Advanced Photon Source, Argonne National Laboratory.
Data processing and scaling were performed with iMosflm (63). The crystals from high salt conditions (3 m NaCl) are in the P6122 space group with cell dimensions of a = b = 140.7 Å, c = 334.0 Å. Each asymmetric unit contains four protein molecules, corresponding to a Matthews coefficient of 3.46 Å3/Da and a solvent content of 64.5%. The crystals from the PEG 20000 conditions belong to the P21 space group and have unit cell parameters of a = 45.6, b = 81.5, c = 81.4 Å, β = 100.1°. There are two protein molecules per asymmetric unit correspond to a Matthews coefficient of 2.16 Å3/Da and have a solvent content of 43.0%.
The SAD data of 2.70 Å resolution were used to locate the iodide ions with SHELXD (64). Phasing and density modification were performed using Phaser (65) and Refmac5 (66) in CCP4 (67). The initial model built through Autobuild (68) in Phenix (69) was used as the template for molecular replacement through MolRep (70) using the data sets of higher resolution collected from the crystals in the PEG condition. It should be pointed out that, after we solved the structure of ChoE, two new structures (PDB 5XTU (27) and 6JKZ (28), see below for structure comparison) released by the Protein Data Bank turned out to be good templates for the structure solution of ChoE by the molecular replacement approach. For all the structures reported here, multiple cycles of refinement using Refmac5 followed by model rebuilding with Coot (71) were carried out. The ligand molecules were placed in the model based on the electron density maps and refined. For the new ligand PTCh, it was refined using the geometric restraints prepared using REEL (72) in Phenix. All the models have good stereochemistry as analyzed with PROCHECK (73). Data collection and refinement statistics are shown in Table 3. Notably, Ser-145 in all these structures accounts for the 0.4% outlier in the Ramachandran plot.
Table 3.
X-ray data collection and refinement statistics (values in parentheses are for the highest-resolution shell)
| Structure | Phasing data set | WT ChoE MES complex | WT ChoE Product complex (ACT + TCh) | WT ChoE PTCh substrate (or product) complex | H288N ChoE ATCh substrate complex | D285N ChoE product complex (ACT + TCh) | D285N ChoE Acyl-enzyme | S38A ChoE ACT and ATCh complex |
|---|---|---|---|---|---|---|---|---|
| Space group | P6122 | C2221 | P21 | P21 | P21 | P21 | P21 | P21 |
| a, b, c (Å) | 140.7, 140.7, 334.0 | 82.2, 109.7, 84.2 | 45.8, 81.8, 81.4 | 45.6, 81.5, 81.4 | 45.6, 81.5, 81.5 | 45.6, 81.6, 81.4 | 45.7, 81.7, 81.2 | 45.5, 81.6, 81.3 |
| α, β, γ (°) | 90, 90, 120 | 90, 90, 90 | 90, 99.8, 90 | 90, 100.1, 90 | 90, 100.2, 90 | 90, 99.9, 90 | 90, 99.8, 90 | 90, 100.0, 90 |
| Wavelength(Å) | 1.7712 | 0.97931 | 0.97931 | 0.97931 | 0.97931 | 0.97931 | 0.97931 | 0.97931 |
| Resolution (Å) | 50-2.70 (2.80-2.70) | 50-1.35 (1.42-1.35) | 50-1.65 (1.74-1.65) | 50-1.85 (1.95-1.85) | 50-1.57 (1.65-1.57) | 50-1.43 (1.51-1.43) | 50-1.80 (1.90-1.80) | 50-1.42 (1.50-1.42) |
| Observed hkl | 1,167,343 | 526,567 (66,425) | 220,070 (32,265) | 338,188 (49,627) | 538,220 (77,703) | 353,033 (42,760) | 164,957 (14,704) | 365,050 (51,557) |
| Unique hkl | 54,461 (5,311) | 82,957 (11,819) | 68,456 (10,091) | 49,649 (7,199) | 79,982 (11,661) | 104,293 (13,769) | 48,219 (4,750) | 106,729 (15,506) |
| Redundancy | 21.4 (21.5) | 6.3 (5.6) | 3.2 (3.2) | 6.8 (6.9) | 6.7 (6.7) | 3.4 (3.1) | 3.4 (3.1) | 3.4 (3.3) |
| Completeness (%) | 100 (100) | 99.5 (98.0) | 96.5 (97.9) | 99.2 (99.2) | 97.7 (98.2) | 96.4 (87.3) | 88.7 (60.2) | 97.0 (97.0) |
| Rmeas | 0.198 (0.842) | 0.055 (0.883) | 0.123 (0.550) | 0.162 (1.045) | 0.067 (0.911) | 0.056 (0.643) | 0.071 (0.426) | 0.044 (0.633) |
| CC1/2 | 0.990 (0.947) | 0.999 (0.828) | 0.990 (0.682) | 0.996 (0.833) | 0.999 (0.798) | 0.999 (0.807) | 0.998 (0.874) | 0.999 (0.803) |
| I/(σI) | 25.7 (5.2) | 17.2 (2.2) | 7.6 (2.5) | 9.3 (2.1) | 16.9 (2.2) | 13.3 (2.2) | 13.7 (3.0) | 17.0 (2.5) |
| Wilson B (Å2) | 29.5 | 15.0 | 8.6 | 19.9 | 18.3 | 13.8 | 14.1 | 14.9 |
| Rwork (# hkl) | 0.154 (78,707) | 0.185 (65,063) | 0.191 (47,260) | 0.154 (75,945) | 0.171 (99,062) | 0.145 (45,881) | 0.164 (101,405) | |
| Rfree (# hkl) | 0.177 (4,212) | 0.226 (3,371) | 0.239 (2,361) | 0.183 (3,990) | 0.198 (5,189) | 0.171 (2,316) | 0.194 (5,289) | |
| B-factors (Å2) | ||||||||
| —(# atoms) | ||||||||
| —Protein | 19.3 (2,310) | 16.5 (4,453) | 27.1 (4,449) | 25.5 (4,482) | 21.1 (4,511) | 23.8 (4,494) | 21.1 (4,496) | |
| —Ligand | 36.8 (44) | 28.6 (35) | 38.3 (23) | 39.7 (20) | 30.2 (22) | 36.9 (14) | 29.7 (28) | |
| —Water | 35.6 (403) | 27.0 (593) | 33.7 (344) | 37.3 (617) | 33.4 (650) | 34.7 (609) | 33.8 (690) | |
| Ramachandran | ||||||||
| —Favored (%) | 99.6 | 99.6 | 99.6 | 99.6 | 99.6 | 99.6 | 99.4 | |
| —Generally allowed (%) | 0 | 0 | 0 | 0 | 0 | 0 | 0.2 | |
| —Outlier(%) | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | |
| R.m.s.d. | ||||||||
| —Bonds (Å) | 0.0165 | 0.0115 | 0.0161 | 0.0136 | 0.0145 | 0.0140 | 0.0152 | |
| —Angles (°) | 2.01 | 1.53 | 1.79 | 1.72 | 1.81 | 1.64 | 1.86 | |
| PDB code | 6UQV | 6UQW | 6UQX | 6UQY | 6UQZ | 6UR0 | 6UR1 |
Upon structure determination, a search through the DALI server (26) has given several structures with significant similarity to ChoE, among which are the esterase EstJ15 (PDB 5XTU (27)) with a Z-score of 33.5 and an r.m.s.d. of 2.1 Å for the 268 aligned Cα atoms, the phospholipase A2 VvPlpA (PDB 6JKZ) (28) with a Z-score of 28.5 and an r.m.s.d. of 2.1 Å for the 247 aligned Cα atoms, and the esterase EstA (PDB 3KVN) (29) with a Z-score of 26.3 and an r.m.s.d. of 2.3 Å for the 231 aligned Cα atoms.
Molecular docking
The potential esterase substrates (commercially available from Sigma-Aldrich) were identified and their 3D coordinates were obtained from the ZINC database (zinc.docking.org) (74) in the MOL2 file format. In addition, we have also prepared the files for propidium and tetraethylammonium, two molecules containing a quaternary ammonium group present in ATCh and PTCh. Docking simulations were performed with the LeDock V1.0 software (75). The protein part of the MES-bound ChoE structure (6UQV) from this work was used, and the receptor was prepared using the LePro software (75). The size of the binding pocket included any protein atom within 10 Å of any heavy atom of the MES molecule in the active site pocket. The number of binding poses and r.m.s.d. were set to 20 and 0.5 Å, respectively. Validation of the docking protocol was carried out by using self-docking of MES, leading to an r.m.s.d. of 0.79 Å between the docked pose and the crystallographic structure. Following a visual inspection of the docked poses of the potential substrates or inhibitors, we selected pNPA, pNPP, pNPB, pNPO, propidium, and tetraethylammonium for activity or inhibition assays.
Data availability
The coordinates and structure factors of the structures reported here have been deposited in the Protein Data Bank under the accession numbers 6UQV, 6UQW, 6UQX, 6UQY, 6UQZ, 6UR0, and 6UR1. All remaining data are contained within the article and supporting information.
Supplementary Material
Acknowledgments
We thank Professor Michel Guertin for insightful discussions. S. J. C. is a research scholar of the Fonds de Recherche du Québec en Santé. The P. aeruginosa PAO1 deletion mutant strain (PW9287) used in this study was generated through support from National Institutes of Health Grant P30 DK089507. Part of the research described in this paper was performed using beamline 08ID-1 at the Canadian Light Source, a national research facility of the University of Saskatchewan, which is supported by the Canada Foundation for Innovation (CFI), the Natural Sciences and Engineering Research Council (NSERC), the National Research Council (NRC), the Canadian Institutes of Health Research (CIHR), the Government of Saskatchewan, and the University of Saskatchewan. The SAD data were collected by Shaun Labiuk. This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract number DE-AC02-06CH11357. Use of the Lilly Research Laboratories Collaborative Access Team (LRL-CAT) beamline at Sector 31 of the Advanced Photon Source was provided by Eli Lilly Company, which operates the facility.
This article contains supporting information.
Author contributions—V. D. P. and M. C. data curation; V. D. P., C. G.-T., M. C., P. L., D. Y., L.-A. L., and R. S. formal analysis; V. D. P., M. C., M.-È. P., and R. S. validation; V. D. P., T. A. T., C. G.-T., M. C., P. L., S. A. A., and R. S. investigation; V. D. P., M. C., X. Z., and R. S. visualization; V. D. P., T. A. T., C. G.-T., M. C., P. L., D. Y., L.-A. L., S. A. A., S. J. C., and R. S. methodology; V. D. P. and R. S. writing-original draft; V. D. P., C. G.-T, M. C., P. L., M.-È. P., L.-A. L., R. C. L., S. J. C., and R. S. writing-review and editing; M. C., P. L., D. Y., and X. Z. software; L.-A. L., R. C. L., and S. J. C. resources; R. S. conceptualization; R. C. L., S. J. C., and R. S. supervision; R. C. L., S. J. C., and R. S. funding acquisition.
Funding and additional information—This work was supported by Grant 183530 from the Fonds de Recherche du Québec–Nature et technologies (FRQNT) (to R. C. L., S. J. C., and R. S.) and Canada Foundation for Innovation (CFI) John R. Evans Leaders Fund Grant 33092 (to R. S.).
Conflict of interest—The authors declare that they have no conflicts of interest with the contents of this article.
- AChE
- acetylcholinesterase
- ACh
- acetylcholine
- ATCh
- acetylthiocholine
- PTCh
- propionylthiocholine
- BTCh
- butyrylthiocholine
- TCh
- thiocholine
- ACT
- acetate
- CAS
- catalytic anionic site
- PAS
- peripheral anionic site
- pNPA
- 4-nitrophenyl acetate
- pNPP
- 4-nitrophenyl propionate
- pNPB
- 4-nitrophenyl butyrate
- pNPO
- 4-nitrophenyl octanoate
- PI
- propidium iodide
- TEAC
- tetraethylammonium chloride
- PDB
- Protein Data Bank
- SAD
- single-wavelength anomalous dispersion
- r.m.s.d.
- root mean square deviation
- EIS
- acyl-enzyme intermediate substrate complex
- EPS
- enzyme product-substrate ternary complex
- ESS
- enzyme-substrate-substrate complex.
References
- 1. Tougu V. (2001) Acetylcholinesterase: mechanism of catalysis and inhibition. Curr. Med. Chem. Central Nervous Syst. Agents 1, 155–170 10.2174/1568015013358536 [DOI] [Google Scholar]
- 2. Quinn D. M. (1987) Acetylcholinesterase: enzyme structure, reaction dynamics, and virtual transition states. Chem. Rev. 87, 955–979 10.1021/cr00081a005 [DOI] [Google Scholar]
- 3. Rauwerdink A., and Kazlauskas R. J. (2015) How the same core catalytic machinery catalyzes 17 different reactions: the serine-histidine-aspartate catalytic triad of α/β-hydrolase fold enzymes. ACS Catal. 5, 6153–6176 10.1021/acscatal.5b01539 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Colović M. B., Krstić D. Z., Lazarević-Pašti T. D., Bondžić A. M., and Vasić V. M. (2013) Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr. Neuropharmacol. 11, 315–335 10.2174/1570159X11311030006 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Sussman J., Harel M., Frolow F., Oefner C., Goldman A., Toker L., and Silman I. (1991) Atomic structure of acetylcholinesterase from Torpedo californica: a prototypic acetylcholine-binding protein. Science 253, 872–879 10.1126/science.1678899 [DOI] [PubMed] [Google Scholar]
- 6. Dvir H., Silman I., Harel M., Rosenberry T. L., and Sussman J. L. (2010) Acetylcholinesterase: from 3D structure to function. Chem. Biol. Interact. 187, 10–22 10.1016/j.cbi.2010.01.042 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Silman I., and Sussman J. L. (2017) Recent developments in structural studies on acetylcholinesterase. J. Neurochem. 142, 19–25 10.1111/jnc.13992 [DOI] [PubMed] [Google Scholar]
- 8. Cavalcante S. F. A., Simas A. B. C., Barcellos M. C., de Oliveira V. G. M., Sousa R. B., Cabral P. A. M., Kuca K., and Franca T. C. C. (2020) Acetylcholinesterase: the “Hub” for neurodegenerative diseases and chemical weapons convention. Biomolecules 10, e414 10.3390/biom10030414 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Bourne Y., Renault L., and Marchot P. (2015) Crystal structure of snake venom acetylcholinesterase in complex with inhibitory antibody fragment Fab410 bound at the peripheral site: evidence for open and closed states of a back door channel. J. Biol. Chem. 290, 1522–1535 10.1074/jbc.M114.603902 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Bourne Y., Sharpless K. B., Taylor P., and Marchot P. (2016) Steric and dynamic parameters influencing in situ cycloadditions to form triazole inhibitors with crystalline acetylcholinesterase. J. Am. Chem. Soc. 138, 1611–1621 10.1021/jacs.5b11384 [DOI] [PubMed] [Google Scholar]
- 11. Lazarevic-Pasti T., Leskovac A., Momic T., Petrovic S., and Vasic V. (2017) Modulators of acetylcholinesterase activity: from Alzheimer's disease to anti-cancer drugs. Curr. Med. Chem. 24, 3283–3309 10.2174/0929867324666170705123509 [DOI] [PubMed] [Google Scholar]
- 12. Sánchez D. G., Otero L. H., Hernández C. M., Serra A. L., Encarnación S., Domenech C. E., and Lisa A. T. (2012) A Pseudomonas aeruginosa PAO1 acetylcholinesterase is encoded by the PA4921 gene and belongs to the SGNH hydrolase family. Microbiol. Res. 167, 317–325 10.1016/j.micres.2011.11.005 [DOI] [PubMed] [Google Scholar]
- 13. Azam M. W., and Khan A. U. (2019) Updates on the pathogenicity status of Pseudomonas aeruginosa. Drug. Discov. Today 24, 350–359 10.1016/j.drudis.2018.07.003 [DOI] [PubMed] [Google Scholar]
- 14. Goldstein D. B., and Goldstein A. (1953) An adaptive bacterial cholinesterase from Pseudomonas species. J. Gen. Microbiol. 8, 8–17 10.1099/00221287-8-1-8 [DOI] [PubMed] [Google Scholar]
- 15. Rochu D., Rothlisberger C., Taupin C., Renault F., Gagnon J., and Masson P. (1998) Purification, molecular characterization and catalytic properties of a Pseudomonas fluorescens enzyme having cholinesterase-like activity. Biochim. Biophys. Acta 1385, 126–138 10.1016/S0167-4838(98)00042-9 [DOI] [PubMed] [Google Scholar]
- 16. Garber N., and Nachshon I. (1980) Localization of cholinesterase in Pseudomonas aeruginosa strain K. J. Gen. Microbiol. 117, 279–283 10.1099/00221287-117-1-279 [DOI] [PubMed] [Google Scholar]
- 17. Pesin S. R., and Candia O. A. (1982) Acetylcholine concentration and its role in ionic transport by the corneal epithelium. Invest. Ophthalmol. Vis. Sci. 22, 651–659 [PubMed] [Google Scholar]
- 18. Domenech C. E., Garrido M. N., and Lisa T. A. (1991) Pseudomonas aeruginosa cholinesterase and phosphorylcholine phosphatase: two enzymes contributing to corneal infection. FEMS Microbiol. Lett. 82, 131–135 10.1111/j.1574-6968.1991.tb04853.x [DOI] [PubMed] [Google Scholar]
- 19. Lisa T. A., Lucchesi G. I., and Domenech C. E. (1994) Pathogenicity of Pseudomonas aeruginosa and its relationship to the choline metabolism through the action of cholinesterase, acid phosphatase, and phospholipase C. Curr. Microbiol. 29, 193–199 10.1007/BF01570153 [DOI] [PubMed] [Google Scholar]
- 20. Wargo M. J. (2013) Choline catabolism to glycine betaine contributes to Pseudomonas aeruginosa survival during murine lung infection. PLoS ONE 8, e56850 10.1371/journal.pone.0056850 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Krupka R. M. (1963) The mechanism of action of acetylcholinesterase: substrate inhibition and the binding of inhibitors. Biochemistry 2, 76–82 10.1021/bi00901a015 [DOI] [PubMed] [Google Scholar]
- 22. Bourne Y., Taylor P., Radic Z., and Marchot P. (2003) Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site. EMBO J. 22, 1–12 10.1093/emboj/cdg005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Rosenberry T. L., Brazzolotto X., Macdonald I. R., Wandhammer M., Trovaslet-Leroy M., Darvesh S., and Nachon F. (2017) Comparison of the binding of reversible inhibitors to human butyrylcholinesterase and acetylcholinesterase: a crystallographic, kinetic and calorimetric study. Molecules 22, 2098 10.3390/molecules22122098 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24. Mølgaard A., Kauppinen S., and Larsen S. (2000) Rhamnogalacturonan acetylesterase elucidates the structure and function of a new family of hydrolases. Structure 8, 373–383 10.1016/S0969-2126(00)00118-0 [DOI] [PubMed] [Google Scholar]
- 25. Akoh C. C., Lee G.-C., Liaw Y.-C., Huang T.-H., and Shaw J.-F. (2004) GDSL family of serine esterases/lipases. Prog. Lipid Res. 43, 534–552 10.1016/j.plipres.2004.09.002 [DOI] [PubMed] [Google Scholar]
- 26. Holm L., and Rosenström P. (2010) Dali server: conservation mapping in 3D. Nucleic Acids Res. 38, W545–W549 10.1093/nar/gkq366 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Mazlan S., Ali M. S. M., Rahman R., Sabri S., Jonet M. A., and Leow T. C. (2018) Crystallization and structure elucidation of GDSL esterase of photobacterium sp. J15. Int. J. Biol. Macromol. 119, 1188–1194 10.1016/j.ijbiomac.2018.08.022 [DOI] [PubMed] [Google Scholar]
- 28. Wan Y., Liu C., and Ma Q. (2019) Structural analysis of a Vibrio phospholipase reveals an unusual Ser-His-chloride catalytic triad. J. Biol. Chem. 294, 11391–11401 10.1074/jbc.RA119.008280 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. van den Berg B. (2010) Crystal structure of a full-length autotransporter. J. Mol. Biol. 396, 627–633 10.1016/j.jmb.2009.12.061 [DOI] [PubMed] [Google Scholar]
- 30. Hedstrom L. (2002) Serine protease mechanism and specificity. Chem. Rev. 102, 4501–4524 10.1021/cr000033x [DOI] [PubMed] [Google Scholar]
- 31. Lo Y. C., Lin S. C., Shaw J. F., and Liaw Y. C. (2003) Crystal structure of Escherichia coli thioesterase I/protease I/lysophospholipase L1: consensus sequence blocks constitute the catalytic center of SGNH-hydrolases through a conserved hydrogen bond network. J. Mol. Biol. 330, 539–551 10.1016/S0022-2836(03)00637-5 [DOI] [PubMed] [Google Scholar]
- 32. Shi R., Lamb S. S., Bhat S., Sulea T., Wright G. D., Matte A., and Cygler M. (2007) Crystal structure of StaL, a glycopeptide antibiotic sulfotransferase from Streptomyces toyocaensis. J. Biol. Chem. 282, 13073–13086 10.1074/jbc.M611912200 [DOI] [PubMed] [Google Scholar]
- 33. Shi R., McDonald L., Cui Q., Matte A., Cygler M., and Ekiel I. (2011) Structural and mechanistic insight into covalent substrate binding by Escherichia coli dihydroxyacetone kinase. Proc. Natl. Acad. Sci. U.S.A. 108, 1302–1307 10.1073/pnas.1012596108 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Colletier J. P., Fournier D., Greenblatt H. M., Stojan J., Sussman J. L., Zaccai G., Silman I., and Weik M. (2006) Structural insights into substrate traffic and inhibition in acetylcholinesterase. EMBO J. 25, 2746–2756 10.1038/sj.emboj.7601175 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Bourne Y., Radic Z., Sulzenbacher G., Kim E., Taylor P., and Marchot P. (2006) Substrate and product trafficking through the active center gorge of acetylcholinesterase analyzed by crystallography and equilibrium binding. J. Biol. Chem. 281, 29256–29267 10.1074/jbc.M603018200 [DOI] [PubMed] [Google Scholar]
- 36. Ollis D. L., Cheah E., Cygler M., Dijkstra B., Frolow F., Franken S. M., Harel M., Remington S. J., Silman I., Schrag J., Sussman J. L., Verschueren K. H. G., and Goldman A. (1992) The α/β hydrolase fold. Protein Eng. 5, 197–211 10.1093/protein/5.3.197 [DOI] [PubMed] [Google Scholar]
- 37. Dimitriou P. S., Denesyuk A. I., Nakayama T., Johnson M. S., and Denessiouk K. (2019) Distinctive structural motifs co-ordinate the catalytic nucleophile and the residues of the oxyanion hole in the α/β-hydrolase fold enzymes. Protein Sci. 28, 344–364 10.1002/pro.3527 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Hofer P., and Fringeli U. P. (1981) Acetylcholinesterase kinetics. Biophys. Struct. Mech. 8, 45–59 10.1007/BF01047105 [DOI] [PubMed] [Google Scholar]
- 39. Taylor P., and Radic Z. (1994) The cholinesterases: from genes to proteins. Annu. Rev. Pharmacol. Toxicol. 34, 281–320 10.1146/annurev.pa.34.040194.001433 [DOI] [PubMed] [Google Scholar]
- 40. Olsen J. A., Balle T., Gajhede M., Ahring P. K., and Kastrup J. S. (2014) Molecular recognition of the neurotransmitter acetylcholine by an acetylcholine binding protein reveals determinants of binding to nicotinic acetylcholine receptors. PLoS ONE 9, e91232 10.1371/journal.pone.0091232 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Hermoso J. A., Monterroso B., Albert A., Galán B., Ahrazem O., García P., Martínez-Ripoll M., García J. L., and Menéndez M. (2003) Structural basis for selective recognition of pneumococcal cell wall by modular endolysin from phage Cp-1. Structure 11, 1239–1249 10.1016/j.str.2003.09.005 [DOI] [PubMed] [Google Scholar]
- 42. Pittelkow M., Tschapek B., Smits S. H., Schmitt L., and Bremer E. (2011) The crystal structure of the substrate-binding protein OpuBC from Bacillus subtilis in complex with choline. J. Mol. Biol. 411, 53–67 10.1016/j.jmb.2011.05.037 [DOI] [PubMed] [Google Scholar]
- 43. Shafferman A., Kronman C., Flashner Y., Leitner M., Grosfeld H., Ordentlich A., Gozes Y., Cohen S., Ariel N., Barak D., Harel M., Silman I., Sussman J. L., and Velan B. (1992) Mutagenesis of human acetylcholinesterase: identification of residues involved in catalytic activity and in polypeptide folding. J. Biol. Chem. 267, 17640–17648 [PubMed] [Google Scholar]
- 44. Riley L. M., Weadge J. T., Baker P., Robinson H., Codee J. D., Tipton P. A., Ohman D. E., and Howell P. L. (2013) Structural and functional characterization of Pseudomonas aeruginosa AlgX: role of AlgX in alginate acetylation. J. Biol. Chem. 288, 22299–22314 10.1074/jbc.M113.484931 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Alalouf O., Balazs Y., Volkinshtein M., Grimpel Y., Shoham G., and Shoham Y. (2011) A new family of carbohydrate esterases is represented by a GDSL hydrolase/acetylxylan esterase from Geobacillus stearothermophilus. J. Biol. Chem. 286, 41993–42001 10.1074/jbc.M111.301051 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Ding J. M., Yu T. T., Han N. Y., Yu J. L., Li J. J., Yang Y. J., Tang X. H., Xu B., Zhou J. P., Tang H. Z., and Huang Z. X. (2016) Identification and characterization of a new 7-aminocephalosporanic acid deacetylase from thermophilic bacterium Alicyclobacillus tengchongensis. J. Bacteriol. 198, 311–320 10.1128/JB.00471-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Baker P., Ricer T., Moynihan P. J., Kitova E. N., Walvoort M. T., Little D. J., Whitney J. C., Dawson K., Weadge J. T., Robinson H., Ohman D. E., Codee J. D., Klassen J. S., Clarke A. J., and Howell P. L. (2014) P. aeruginosa SGNH hydrolase-like proteins AlgJ and AlgX have similar topology but separate and distinct roles in alginate acetylation. PLoS Pathog. 10, e1004334 10.1371/journal.ppat.1004334 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Lee L. C., Lee Y. L., Leu R. J., and Shaw J. F. (2006) Functional role of catalytic triad and oxyanion hole-forming residues on enzyme activity of Escherichia coli thioesterase I/protease I/phospholipase L1. Biochem. J. 397, 69–76 10.1042/BJ20051645 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Ghosh D., Sawicki M., Lala P., Erman M., Pangborn W., Eyzaguirre J., Gutierrez R., Jornvall H., and Thiel D. J. (2001) Multiple conformations of catalytic serine and histidine in acetylxylan esterase at 0.90 Å. J. Biol. Chem. 276, 11159–11166 10.1074/jbc.M008831200 [DOI] [PubMed] [Google Scholar]
- 50. Kawasaki K., Kondo H., Suzuki M., Ohgiya S., and Tsuda S. (2002) Alternate conformations observed in catalytic serine of Bacillus subtilis lipase determined at 1.3 Å resolution. Acta Crystallogr. D Biol. Crystallogr. 58, 1168–1174 10.1107/S090744490200714X [DOI] [PubMed] [Google Scholar]
- 51. Zhu X., Larsen N. A., Basran A., Bruce N. C., and Wilson I. A. (2003) Observation of an arsenic adduct in an acetyl esterase crystal structure. J. Biol. Chem. 278, 2008–2014 10.1074/jbc.M210103200 [DOI] [PubMed] [Google Scholar]
- 52. McAuley K. E., Svendsen A., Patkar S. A., and Wilson K. S. (2004) Structure of a feruloyl esterase from Aspergillus niger. Acta Crystallogr. D Biol. Crystallogr. 60, 878–887 10.1107/S0907444904004937 [DOI] [PubMed] [Google Scholar]
- 53. Zhou Y., Wang S., and Zhang Y. (2010) Catalytic reaction mechanism of acetylcholinesterase determined by Born-Oppenheimer ab initio QM/MM molecular dynamics simulations. J. Phys. Chem. B 114, 8817–8825 10.1021/jp104258d [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54. Omelchenko M. V., Galperin M. Y., Wolf Y. I., and Koonin E. V. (2010) Non-homologous isofunctional enzymes: a systematic analysis of alternative solutions in enzyme evolution. Biol. Direct. 5, 31 10.1186/1745-6150-5-31 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55. Galperin M. Y., and Koonin E. V. (2012) Divergence and convergence in enzyme evolution. J. Biol. Chem. 287, 21–28 10.1074/jbc.R111.241976 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Elias M., and Tawfik D. S. (2012) Divergence and convergence in enzyme evolution: parallel evolution of paraoxonases from quorum-quenching lactonases. J. Biol. Chem. 287, 11–20 10.1074/jbc.R111.257329 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57. Gibney G., Camp S., Dionne M., MacPhee-Quigley K., and Taylor P. (1990) Mutagenesis of essential functional residues in acetylcholinesterase. Proc. Natl. Acad. Sci. U.S.A. 87, 7546–7550 10.1073/pnas.87.19.7546 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Radic Z., Gibney G., Kawamoto S., MacPhee-Quigley K., Bongiorno C., and Taylor P. (1992) Expression of recombinant acetylcholinesterase in a baculovirus system: kinetic properties of glutamate 199 mutants. Biochemistry 31, 9760–9767 10.1021/bi00155a032 [DOI] [PubMed] [Google Scholar]
- 59. Shafferman A., Velan B., Ordentlich A., Kronman C., Grosfeld H., Leitner M., Flashner Y., Cohen S., Barak D., and Ariel N. (1992) Substrate inhibition of acetylcholinesterase: residues affecting signal transduction from the surface to the catalytic center. EMBO J. 11, 3561–3568 10.1002/j.1460-2075.1992.tb05439.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Reed M. C., Lieb A., and Nijhout H. F. (2010) The biological significance of substrate inhibition: a mechanism with diverse functions. Bioessays 32, 422–429 10.1002/bies.200900167 [DOI] [PubMed] [Google Scholar]
- 61. Ellman G. L., Courtney K. D., Andres V., and Feather-Stone R. M. (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7, 88–95 10.1016/0006-2952(61)90145-9 [DOI] [PubMed] [Google Scholar]
- 62. Domenech C. E., Garrido M. N., Machado de Domenech E. E., and Lisa T. A. (1981) Acetylcholinesterase from rat red cells and cholinesterase of Pseudomonas aeruginosa: different types of inhibition by atropine. Mol. Cell. Biochem. 34, 95–99 10.1007/BF02354863 [DOI] [PubMed] [Google Scholar]
- 63. Leslie A. G. W., and Powell H. R. (2007) Processing diffraction data with mosflm. in Evolving methods for macromolecular crystallography, NATO Science Series (Read R. J. and Sussman J. L., eds), Vol. 245, pp. 41–51, Springer, Dordrecht, Netherlands [Google Scholar]
- 64. Schneider T. R., and Sheldrick G. M. (2002) Substructure solution with SHELXD. Acta Crystallogr. D Biol. Crystallogr. 58, 1772–1779 10.1107/S0907444902011678 [DOI] [PubMed] [Google Scholar]
- 65. McCoy A. J., Grosse-Kunstleve R. W., Adams P. D., Winn M. D., Storoni L. C., and Read R. J. (2007) Phaser crystallographic software. J. Appl. Cryst. 40, 658–674 10.1107/S0021889807021206 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. Murshudov G. N., Vagin A. A., and Dodson E. J. (1997) Refinement of macromolecular structures by the maximum-likelihood method. Crystallogr. D Biol. Crystallogr. 53, 240–255 10.1107/S0907444996012255 [DOI] [PubMed] [Google Scholar]
- 67. Winn M. D., Ballard C. C., Cowtan K. D., Dodson E. J., Emsley P., Evans P. R., Keegan R. M., Krissinel E. B., Leslie A. G. W., McCoy A., McNicholas S. J., Murshudov G. N., Pannu N. S., Potterton E. A., Powell H. R., et al. (2011) Overview of the CCP4 suite and current developments. Acta Crystallogr. D Biol. Crystallogr. 67, 235–242 10.1107/S0907444910045749 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68. Terwilliger T. C., Grosse-Kunstleve R. W., Afonine P. V., Moriarty N. W., Zwart P. H., Hung L. W., Read R. J., and Adams P. D. (2008) Iterative model building, structure refinement and density modification with the PHENIX autobuild wizard. Acta Crystallogr. D Biol. Crystallogr. 64, 61–69 10.1107/S090744490705024X [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69. Adams P. D., Afonine P. V., Bunkoczi G., Chen V. B., Davis I. W., Echols N., Headd J. J., Hung L. W., Kapral G. J., Grosse-Kunstleve R. W., McCoy A. J., Moriarty N. W., Oeffner R., Read R. J., Richardson D. C., et al. (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221 10.1107/S0907444909052925 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 70. Vagin A., and Teplyakov A. (1997) MOLREP: an automated program for molecular replacement. J. Appl. Cryst. 30, 1022–1025 10.1107/S0021889897006766 [DOI] [Google Scholar]
- 71. Emsley P., and Cowtan K. (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126–2132 10.1107/S0907444904019158 [DOI] [PubMed] [Google Scholar]
- 72. Moriarty N. W., Draizen E. J., and Adams P. D. (2017) An editor for the generation and customization of geometry restraints. Acta Crystallogr. D Struct. Biol. 73, 123–130 10.1107/S2059798316016570 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73. Laskowski R. A., MacArthur M. W., Moss D. S., and Thornton J. M. (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Cryst. 26, 283–291 10.1107/S0021889892009944 [DOI] [Google Scholar]
- 74. Irwin J. J., and Shoichet B. K. (2005) ZINC: a free database of commercially available compounds for virtual screening. J. Chem. Inf. Model 45, 177–182 10.1021/ci049714+ [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75. Zhang N., and Zhao H. (2016) Enriching screening libraries with bioactive fragment space. Bioorg. Med. Chem. Lett 26, 3594–3597 10.1016/j.bmcl.2016.06.013 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The coordinates and structure factors of the structures reported here have been deposited in the Protein Data Bank under the accession numbers 6UQV, 6UQW, 6UQX, 6UQY, 6UQZ, 6UR0, and 6UR1. All remaining data are contained within the article and supporting information.






